MRK · News · 20261031N

Revenue Performance and Mix

Merck & Co., Inc. · 2026-10-31 · Importance 25 · Surprise 14 · No source text

Merck reported Q3 2026 revenue of $18.09 billion, up 4.7% year over year. Keytruda and other product growth drove the results, according to the reporting. A separate earnings recap put quarterly revenue at about $18.1 billion and basic EPS at roughly $2.04.

Key facts

• Merck Q3 2026 sales increased 4.7% year on year to $18.09 billion. source
• Merck Q3 2026 revenue was about $18.1 billion. source
• Merck reported adjusted earnings of $2.49 per share and revenue of $18.09 billion. source
• Merck's Q3 2026 non-GAAP profit was $2.49 per share, 19.3% above analysts' consensus estimates. source
• Merck Q3 2026 basic earnings per share was roughly $2.04. source

Impact estimates